Insmed (INSM) Accumulated Expenses (2010 - 2024)

Insmed's Accumulated Expenses history runs 15 years deep, the most recent figure standing at $248.7 million for Q3 2024.

• On a quarterly basis, Accumulated Expenses rose 32.43% year-over-year to $248.7 million in Q3 2024; TTM through Sep 2024 was $248.7 million, a 32.43% increase from a year earlier, with the FY2023 full-year figure at $215.0 million, up 18.05% from the prior year.
• Accumulated Expenses slipped to $248.7 million in Q3 2024 per INSM's latest filing, from $290.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $290.8 million in Q2 2024 and bottomed at $8.9 million in Q1 2020.
• The 5-year median for Accumulated Expenses is $125.0 million (2021), against an average of $114.6 million.
• Across the five-year window, Accumulated Expenses tumbled 76.64% in 2020 and soared 1212.45% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $25.6 million in 2020, then jumped by 388.57% to $125.0 million in 2021, then surged by 45.66% to $182.1 million in 2022, then advanced by 18.05% to $215.0 million in 2023, then grew by 15.67% to $248.7 million in 2024.
• Per Business Quant, the three latest INSM Accumulated Expenses figures stand at $248.7 million (Q3 2024), $290.8 million (Q2 2024), and $189.4 million (Q1 2024).